Sriram Ramanan, PhD

Dr. Sriram Ramanan brings more than 12 years of combined preclinical and clinical contract research organization experience across broad therapeutic areas including oncology, immunology and cell/gene therapy. He joined Labcorp Drug Development in 2014. As part of the global flow cytometry team between 2014 and 2022, he led numerous CAP-/CLIA-compliant assay validations within Labcorp Central Laboratory Services and played a significant role in the expansion of the flow cytometry services within the Asia-Pacific region (Singapore, China and Japan).

In his current role as associate director within the Biomarker Solution Center, he is actively engaged in providing scientific leadership and partnering with clients to define oncology biomarker strategies for their clinical program success.

He received his BS from the National University of Singapore and his PhD in cancer biology from the Wake Forest University School of Medicine (North Carolina).